Skip to main content
. 2019 Jul 26;8(1):135–145. doi: 10.1080/21556660.2019.1649266

Figure 3.

Figure 3.

Results of fixed-effects time-varying hazards network meta-analyses for recurrence-free survival (a) in Stage III melanoma patients with treatment effects as hazard ratio over time relative to observation under the best-fitting second order fractional polynomial model, (p1 = 0, p2 = 0) and (b) in BRAF + melanoma patients with treatment effects as hazard ratio over time relative to observation under the best-fitting 2nd order fractional polynomial model (p1 = 0, p2 = 0).